Login
Super Investors ARMISTICE CAPITAL, LLC
AC

ARMISTICE CAPITAL, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$8.16B
Positions
346
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (48 quarters reported)

$8.4B $208M
Q4 14 Q2 17 Q4 19 Q2 22 Q4 24 Q3 26

$208M in Q4 2014 → $8.16B now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
SS State Str SPDR S&P 500 ETF T Call 31.3% New 3,350,000 $2.55B
IT Ishares Tr Call 22.5% New 6,600,000 $1.83B
Cytokinetics Inc Call 2.1% Added 67% 2,560,000 $169M
Madrigal Pharmaceuticals Inc Call 1.6% New 255,000 $129M
Agios Pharmaceuticals Inc Call 1.3% Added 18% 3,305,100 $110M
Supernus Pharmaceuticals 1.3% Trimmed 3.7% 2,548,000 $110M
Ptc Therapeutics Inc Call 1.3% Added 141% 1,590,000 $103M
Agios Pharmaceuticals Inc 1.1% Added 7.4% 2,578,000 $85.7M
Ptc Therapeutics Inc 1.0% Added 21% 1,297,510 $84.1M
Neurocrine Biosciences Inc 1.0% Added 5.5% 565,251 $80.2M
Cytokinetics Inc 1.0% Trimmed 1.8% 1,180,192 $77.8M
Travere Therapeutics Inc 0.9% Trimmed 18% 1,289,768 $75.9M
Rigel Pharmaceuticals Inc 0.9% Trimmed 8.1% 1,536,000 $74M
Incyte Corp 0.9% Trimmed 33% 600,045 $72.8M
Neurocrine Biosciences Inc Call 0.9% New 500,000 $70.9M
Ironwood Pharmaceuticals Inc 0.7% Added 7.7% 15,000,000 $59.6M
Immunovant Inc 0.7% Added 0.1% 1,738,169 $58.7M
HB Harmony Biosciences Hldgs In 0.7% Trimmed 8.2% 1,436,000 $56.4M
Immunovant Inc Call 0.7% Added 35% 1,625,000 $54.9M
Freshpet Inc 0.6% Trimmed 30% 888,694 $51.2M
Madrigal Pharmaceuticals Inc 0.6% Trimmed 68% 92,024 $46.4M
Amazon Com Inc 0.6% Trimmed 35% 185,827 $46.3M
Verastem Inc 0.6% Trimmed 19% 5,724,000 $46.1M
Mineralys Therapeutics Inc 0.5% Added 1.8% 1,768,000 $44.4M
Dyne Therapeutics Inc 0.5% Trimmed 13% 2,678,060 $43.1M
Regeneron Pharmaceuticals 0.5% Trimmed 37% 56,736 $43M
Travere Therapeutics Inc Call 0.5% Added 44% 720,000 $42.4M
Nektar Therapeutics 0.5% Trimmed 3.3% 700,000 $42.4M
Mineralys Therapeutics Inc Call 0.5% Added 54% 1,600,000 $40.2M
Mongodb Inc 0.5% Trimmed 13% 108,340 $37.8M
Gsk PLC 0.4% Added 141% 724,000 $34.9M
IH Immunocore Hldgs PLC 0.4% Trimmed 20% 1,136,000 $34.4M
Intuitive Surgical Inc 0.4% Added 72% 83,886 $34.1M
OM Orthofix Med Inc 0.4% Added 11% 3,624,000 $34.1M
SS Sanofi Sa 0.4% Trimmed 23% 824,000 $34M
Uber Technologies Inc 0.4% Trimmed 2.3% 486,649 $33.3M
Microsoft Corp 0.4% Trimmed 20% 64,661 $33.2M
Unitedhealth Group Inc 0.4% Trimmed 51% 90,000 $33M
Disc Medicine Inc 0.4% Added 8.7% 500,000 $32.7M
Alphabet Inc 0.4% Trimmed 25% 95,000 $32.7M
Solid Biosciences Inc 0.4% Added 5.1% 4,496,000 $32.5M
Gitlab Inc 0.4% Trimmed 38% 660,704 $31.2M
Five9 Inc 0.4% Trimmed 43% 876,000 $29.8M
Axogen Inc 0.4% Trimmed 11% 692,000 $29M
Dentsply Sirona Inc 0.4% Trimmed 12% 3,236,000 $28.7M
Intellia Therapeutics Inc 0.3% Added 58% 2,364,000 $28.5M
Wynn Resorts Ltd 0.3% Added 37% 357,036 $28.4M
TM Treace Med Concepts Inc 0.3% Unchanged 6,364,000 $28.3M
4M 4d Molecular Therapeutics In 0.3% Trimmed 2.5% 1,950,000 $27.9M
AG Alibaba Group Hldg Ltd 0.3% Added 49% 250,000 $26.9M
Autolus Therapeutics Ltd 0.3% Trimmed 8.3% 13,750,000 $26.7M
Align Technology Inc 0.3% Trimmed 1.4% 177,704 $25.8M
Uipath Inc Call 0.3% New 2,000,000 $25.7M
Hubspot Inc Call 0.3% New 125,000 $25.6M
Hubspot Inc 0.3% Trimmed 32% 120,183 $24.6M
Angiodynamics Inc 0.3% Trimmed 30% 1,536,000 $23.6M
M Macrogenics Inc 0.3% Added 20% 6,000,000 $23.2M
Reddit Inc 0.3% Added 139% 160,000 $22.8M
Kura Oncology Inc 0.3% Trimmed 43% 2,096,000 $22.4M
Sentinelone Inc 0.3% Trimmed 22% 934,948 $22.2M

Showing top 60 of 346 positions.

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
SS State Str SPDR S&P 500 ETF T New +3,350,000 +$2.55B 31.3%
SS State Str SPDR S&P 500 ETF T Exited −3,200,000 −$2.39B —
IT Ishares Tr New +6,600,000 +$1.83B 22.5%
IT Ishares Tr Exited −5,800,000 −$1.74B —
Madrigal Pharmaceuticals Inc New +255,000 +$129M 1.6%
Madrigal Pharmaceuticals Inc Trimmed −195,976 −$98.8M 0.6%
Neurocrine Biosciences Inc New +500,000 +$70.9M 0.9%
Cytokinetics Inc Added +1,030,000 +$67.9M 2.1%
Thermo Fisher Scientific Inc Trimmed −90,490 −$61.1M 0.3%
Ptc Therapeutics Inc Added +930,000 +$60.2M 1.3%

Showing the 10 largest of 474 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
SS State Str SPDR S&P 500 ETF T Added +1,100,000 +$821M 29.2%
IT Ishares Tr Added +2,300,000 +$691M 21.3%
Travere Therapeutics Inc Trimmed −3,324,878 −$189M 1.1%
Ptc Therapeutics Inc Trimmed −1,003,054 −$81.8M 1.1%
Immunovant Inc Trimmed −1,828,916 −$70.5M 0.8%
Datadog Inc Trimmed −170,885 −$44.5M 0.1%
Cytokinetics Inc Added +436,804 +$37.2M 1.3%
Supernus Pharmaceuticals Added +750,854 +$34.9M 1.5%
Regeneron Pharmaceuticals Added +53,683 +$33.5M 0.7%
SS Sanofi Sa Added +764,000 +$32.6M 0.6%

Showing the 10 largest of 413 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Trimmed −4,600,000 −$1.14B 15.4%
SS State Str SPDR S&P 500 ETF T Trimmed −900,000 −$585M 24.3%
Kenvue Inc Trimmed −3,962,592 −$68.3M —
Immunovant Inc Trimmed −2,182,239 −$54.2M 1.6%
Dentsply Sirona Inc Trimmed −4,298,000 −$49.9M 0.6%
Ptc Therapeutics Inc Trimmed −727,420 −$49.6M 2.5%
Argenx Se Exited −58,000 −$48.8M —
GH Ge Healthcare Technologies I Trimmed −673,711 −$48M 0.1%
Starbucks Corp Exited −549,805 −$46.3M —
Supernus Pharmaceuticals Trimmed −868,653 −$44.9M 1.7%

Showing the 10 largest of 452 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
SS SPDR S&P 500 ETF Tr Added +500,000 +$341M 24.3%
IT Ishares Tr Added +1,100,000 +$271M 23.7%
Travere Therapeutics Inc Trimmed −2,960,109 −$113M 1.7%
Madrigal Pharmaceuticals Inc Added +145,723 +$84.9M 1.8%
Kenvue Inc New +3,992,196 +$68.9M 0.8%
Agios Pharmaceuticals Inc Added +2,272,000 +$61.8M 1.0%
MJ Mdgl Jan6 400.0c Exited −130,000 −$59.6M —
Agios Pharmaceuticals Inc Added +2,100,000 +$57.2M 1.0%
ES Exact Sciences Ord Exited −1,030,465 −$56.4M —
Gsk PLC New +1,000,000 +$49M 0.6%

Showing the 10 largest of 493 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 17, 2025

Company Action Shares changed Value of change % of portfolio
SP Supernus Pharmaceuticals Ord Trimmed −1,976,000 −$94.4M 2.0%
PT Ptc Therapeutics Ord Trimmed −1,458,192 −$89.5M 3.0%
DS Dentsply Sirona Ord Added +5,234,587 +$66.4M 1.1%
TT Travere Therapeutics Ord Trimmed −2,152,000 −$51.4M 2.4%
GA Grifols ADR Rep One Non Vtg Cl B Ord Trimmed −5,062,000 −$50.4M 0.3%
Staar Surgical Co Exited −2,812,000 −$47.2M —
NN Novo Nordisk ADR Repsg 1 Ord New +736,000 +$40.8M 0.6%
FO Freshpet Ord Added +669,399 +$36.9M 1.0%
MO Mcdonald's Ord Trimmed −119,810 −$36.4M 0.1%
AF Agio Feb6 40.0 C New +900,000 +$36.1M 0.5%

Showing the 10 largest of 376 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Added +300,000 +$64.7M 26.1%
Exact Sciences Corp Trimmed −1,030,413 −$54.8M 0.7%
SB Spectrum Brands Hldgs Inc Ne Exited −691,000 −$49.4M —
Simply Good Foods Co Exited −1,351,593 −$46.6M —
Cytokinetics Inc Trimmed −1,360,000 −$44.9M 0.8%
Sensient Technologies Corp Trimmed −446,022 −$43.9M 0.2%
Dominos Pizza Inc Exited −90,068 −$41.4M —
Neurocrine Biosciences Inc Trimmed −324,166 −$40.7M 1.5%
Dentsply Sirona Inc Trimmed −2,498,735 −$39.7M 0.1%
Madrigal Pharmaceuticals Inc Trimmed −130,000 −$39.3M 0.9%

Showing the 10 largest of 262 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
Madrigal Pharmaceuticals Inc New +300,000 +$99.4M 1.5%
Vertex Pharmaceuticals Inc Trimmed −174,016 −$84.4M 0.4%
Cytokinetics Inc Added +2,090,000 +$84M 1.6%
IM Inari Med Inc Exited −1,565,577 −$79.9M —
Gsk PLC Trimmed −2,000,000 −$77.5M 0.2%
Anheuser Busch Inbev Sa/nv Exited −1,359,000 −$68M —
Humana Inc Trimmed −255,977 −$67.7M 0.2%
Freshpet Inc New +716,960 +$59.6M 0.9%
Icon PLC Trimmed −318,060 −$55.7M 0.3%
Regeneron Pharmaceuticals Added +86,028 +$54.6M 1.1%

Showing the 10 largest of 275 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Added +1,600,000 +$354M 20.5%
SS SPDR S&P 500 ETF Tr Added +500,000 +$293M 20.0%
Neurocrine Biosciences Inc Added +710,619 +$97M 1.7%
Exact Sciences Corp New +1,617,000 +$90.9M 1.2%
Icon PLC New +418,112 +$87.7M 1.2%
Cytokinetics Inc Trimmed −1,590,000 −$74.8M 0.4%
Vertex Pharmaceuticals Inc Added +177,887 +$71.6M 1.2%
Gsk PLC Added +1,854,000 +$62.7M 1.1%
Alkermes PLC Exited −1,448,654 −$40.5M —
Ptc Therapeutics Inc Trimmed −856,898 −$38.7M 3.9%

Showing the 10 largest of 294 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support